Table 5 Major resistance patterns identified among bacterial isolates; 1st National Prevalence study, Benin, October 2012

MRSA (n = 142/271)

52.5%

MRSA vancomycin R (n = 11/142)

7.7%

Enterococcus ampicillin R (n = 64/102)

62.7%

Enterococcus vancomycin R (n = 69/102)

67.6%

E. coli cefotaxime R (n = 89/221)

40.2%

E. coli ESBL + (n = 44/221)

20.0%

Acinetobacter baumanii ceftazidimeR (n = 10/10)

100.0%

Pseudomonas aeruginosa ceftazidime R (n = 75/110)

68.2%